Target

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/55 (2006.01) A61K 38/46 (2006.01) C07K 7/08 (2006.01) C07K 16/40 (2006.01) C12N 9/16 (2006.01) C12Q 1/44 (2006.01) G01N 33/573 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2351904

The present invention relates to an isolated target sequence. The target sequence is a splice variant of PDE5 called a PDE5a1, a component of which is presented as SEQ ID No 1. The identified target sequence of the present invention may be used to as a target to identify agents (such as modulators) useful in the prevention and/or treatment of a disease associated with scarring and/or fibrosis or to selectively identify smooth muscle cells and myofibroblasts and myoepithelial cells in samples of normal and diseased tissue from individuals.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Target does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Target, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Target will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1625288

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.